Carsten Brockmeyer
The Power List 2017 – Industry Influencers
Carsten Brockmeyer
Chief Executive Officer, Formycon AG
Carsten is passionate about creating a healthier world by widening access to state-of-the-art therapies. “A pivotal moment for me was designing the strategy and leading the cross-functional team for the development and launch of the world’s first complex biosimilar, Binocrit (epoetin alfa), in 2007.” He adds that he would like to see a trend toward a more collaborative approach to drug development in the future.
